封面
市场调查报告书
商品编码
1946718

2026年全球粒子治疗市场报告

Particle Therapy Global Market Report 2026

出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来,粒子束治疗市场发展迅速,预计将从2025年的13.6亿美元成长到2026年的15.3亿美元,复合年增长率达12.1%。过去几年的成长可归因于癌症发生率的上升、质子治疗技术的早期应用、专业肿瘤中心的建立、支持粒子束治疗的临床证据的不断增加以及学术研究型医院的投资。

预计未来几年粒子治疗市场规模将快速成长,到2030年将达到24.4亿美元,复合年增长率(CAGR)为12.4%。预测期内的成长要素包括:个人化癌症治疗方法的推广、先进肿瘤治疗医疗费用支出的增加、对精准放射治疗需求的增长、加速器系统的技术进步以及新兴医疗市场对该技术的日益普及。预测期内的主要趋势包括:笔射束扫描系统的日益普及、单室粒子治疗中心的装置量不断增长、碳离子治疗的应用日益广泛、精准治疗计划能力的提升以及对儿童肿瘤治疗的日益关注。

癌症患者数量的持续成长预计将推动粒子治疗市场的未来发展。癌症是一组复杂且多样化的疾病,会导致体内细胞异常增生。粒子治疗透过将正离子(质子)加速到高速并将其聚焦于肿瘤,从而实现精准的放射治疗,有效治疗癌症。例如,总部位于法国的政府间组织—国际癌症研究机构(IARC)于2024年4月报告称,2022年全球新增癌症病例约2,000万例,死亡病例约1,000万例。根据人口统计趋势预测,到2050年,每年新增癌症病例数可能达到3,500万例,比2022年增加77%。因此,癌症发生率的上升是推动粒子治疗市场成长的主要因素。

为了获得竞争优势,粒子治疗市场的主要企业正致力于开发创新治疗方法,尤其是质子治疗解决方案。质子治疗技术是一种先进的癌症治疗方法,它利用质子或阳离子将精准的标靶辐射输送到癌细胞。例如,2023年4月,总部位于以色列的高科技医疗公司P-Cure的自适应质子治疗解决方案获得了美国食品药物管理局(FDA)的核准,使其得以在美国销售。这项价格合理的质子治疗技术旨在提供标靶癌症治疗,同时显着降低治疗相关的副作用。 P-Cure的创新直立式解决方案是全球首个获得FDA核准的患者体位摆放调查方法,它使患者能够在坐姿下接受治疗,从而提高患者的舒适度和临床疗效。

目录

第一章执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球粒子治疗市场:吸引力评分及分析
  • 成长潜力分析、竞争评估、策略契合度评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 主要原料、资源和供应商清单
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章 全球市场趋势与策略

  • 关键技术和未来趋势
    • 生物技术、基因组学和精准医学
    • 人工智慧(AI)和自主人工智慧
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 物联网、智慧基础设施和互联生态系统
  • 主要趋势
    • 笔射束扫描系统的应用日益广泛
    • 单室粒子治疗中心的建立日益增多
    • 扩大碳离子疗法的应用
    • 扩展精准治疗计画能力
    • 人们对儿童肿瘤应用的兴趣日益浓厚

第五章 终端用户产业市场分析

  • 医院
  • 癌症治疗中心
  • 学术和研究机构
  • 专科肿瘤诊所
  • 政府医疗机构

第六章 市场:宏观经济情景,包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响,以及新冠疫情对市场的影响

第七章 全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球粒子治疗市场:PESTEL 分析(政治、社会、技术、环境、法律因素、驱动因素和限制因素)
  • 全球粒子治疗市场规模、对比及成长率分析
  • 全球粒子治疗市场表现:规模与成长,2020-2025年
  • 全球粒子治疗市场预测:规模与成长,2025-2030年,2035年预测

第八章 全球潜在市场规模(TAM)

第九章 市场细分

  • 按类型
  • 质子束疗法,重粒子束疗法
  • 按系统
  • 单房间系统,多房间系统
  • 癌症类型
  • 儿童癌症、前列腺癌、肺癌、脑癌和脊髓癌以及其他类型的癌症
  • 最终用户
  • 医院、学术研究机构
  • 按类型细分:质子治疗
  • 笔射束扫描质子治疗、被动散射质子治疗、强度调节质子治疗(IMPT)
  • 按类型细分:重离子疗法
  • 碳离子疗法、氦离子疗法

第十章 区域与国家分析

  • 全球粒子治疗市场:依地区、绩效及预测划分,2020-2025年、2025-2030年预测、2035年预测
  • 全球粒子治疗市场:依国家、绩效及预测划分,2020-2025年、2025-2030年预测、2035年预测

第十一章 亚太市场

第十二章:中国市场

第十三章 印度市场

第十四章 日本市场

第十五章:澳洲市场

第十六章 印尼市场

第十七章 韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第二十章:西欧市场

第21章英国市场

第22章 德国市场

第23章:法国市场

第24章:义大利市场

第25章:西班牙市场

第26章 东欧市场

第27章:俄罗斯市场

第28章 北美市场

第29章:美国市场

第30章:加拿大市场

第31章 南美洲市场

第32章:巴西市场

第33章 中东市场

第34章:非洲市场

第35章 市场监理与投资环境

第36章:竞争格局与公司概况

  • 粒子治疗市场:竞争格局及市场占有率(2024年)
  • 粒子治疗市场:公司估值矩阵
  • 粒子治疗市场:公司概况
    • Hitachi Ltd.
    • Mitsubishi Electric Corporation
    • Sumitomo Heavy Industries Ltd.
    • Varian Medical Systems Inc.
    • IBA Worldwide

第37章:其他领先和创新企业

  • Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips NV, GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.

第38章:全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章:高潜力市场国家、细分市场与策略

  • 2030年粒子治疗市场:提供新机会的国家
  • 粒子治疗市场2030:新兴细分市场机会
  • 粒子治疗市场2030年:成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第41章附录

简介目录
Product Code: ME4MPTHE02_G26Q1

Particle therapy is an advanced cancer treatment that employs charged particles, such as protons or heavier ions, to administer radiation therapy directly to cancerous tumors. This method primarily targets energetic ionizing particles at the tumor location, aiming to improve treatment outcomes for patients with various types of tumors, particularly those that are difficult to treat using conventional radiation therapy.

Two primary types of therapies fall under the umbrella of particle therapy, proton therapy and heavy ion therapy. Proton therapy is a specialized form of radiation therapy employed in cancer treatment. It encompasses both single-room systems and multi-room systems, providing versatility in its application. Proton therapy is utilized for the treatment of various cancers, including but not limited to pediatric cancer, prostate cancer, lung cancer, breast cancer, and cancers affecting the brain and spinal cord. The primary end users of particle therapy are hospitals, academic institutions, and research centers. Particle therapy offers a targeted and precise approach to cancer treatment, minimizing damage to surrounding healthy tissues and enhancing the therapeutic effectiveness of radiation.

Tariffs are impacting the particle therapy market by increasing costs of imported accelerators, beam delivery systems, superconducting magnets, imaging components, and control electronics required for proton and heavy ion therapy systems. North America and Europe are most affected due to reliance on specialized imported equipment, while Asia-Pacific faces higher capital costs for new installations. These tariffs are raising upfront investment requirements and extending project timelines for new therapy centers. However, they are also encouraging local manufacturing partnerships, regional assembly capabilities, and long-term innovation in cost-efficient particle therapy system design.

The particle therapy market research report is one of a series of new reports from The Business Research Company that provides particle therapy market statistics, including particle therapy industry global market size, regional shares, competitors with a particle therapy market share, detailed particle therapy market segments, market trends and opportunities, and any further data you may need to thrive in the particle therapy industry. This particle therapy market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The particle therapy market size has grown rapidly in recent years. It will grow from $1.36 billion in 2025 to $1.53 billion in 2026 at a compound annual growth rate (CAGR) of 12.1%. The growth in the historic period can be attributed to rising cancer incidence rates, early adoption of proton therapy technologies, expansion of specialized oncology centers, increasing clinical evidence supporting particle therapy, investments by academic research hospitals.

The particle therapy market size is expected to see rapid growth in the next few years. It will grow to $2.44 billion in 2030 at a compound annual growth rate (CAGR) of 12.4%. The growth in the forecast period can be attributed to expansion of personalized cancer treatment approaches, increasing healthcare spending on advanced oncology care, growing demand for precision radiation therapies, technological advancements in accelerator systems, rising adoption in emerging healthcare markets. Major trends in the forecast period include increasing adoption of pencil beam scanning systems, rising deployment of single-room particle therapy centers, growing use of carbon ion therapy, expansion of precision treatment planning capabilities, enhanced focus on pediatric oncology applications.

The increasing prevalence of cancer is anticipated to drive the growth of the particle therapy market in the future. Cancer is a complex and varied group of diseases marked by the abnormal growth and multiplication of cells in the body. Particle therapy effectively treats cancer through precise radiation delivery, utilizing positively charged particles (protons) that are accelerated to high speeds and focused on the tumor. For instance, in April 2024, the International Agency for Research on Cancer (IARC), a France-based intergovernmental agency, reported that nearly 20 million new cancer cases were recorded in 2022, resulting in almost 10 million deaths. Projections based on demographic trends indicate that the annual incidence of new cancer cases could reach 35 million by 2050, representing a 77% increase from the 2022 figures. Therefore, the rising prevalence of cancer is a key factor driving the growth of the particle therapy market.

Key companies in the particle therapy market are intensifying their efforts to develop innovative therapies, with a particular focus on proton therapy solutions, to gain a competitive advantage. Proton therapy technology, a sophisticated form of cancer treatment utilizing protons and positively charged particles, delivers precise and targeted radiation to cancer cells. For instance, in April 2023, P-Cure, an Israel-based high-med-tech company, obtained clearance from the United States Food and Drug Administration (USFDA) for its Adaptive Proton Therapy Solution, allowing sales in the USA. This affordable proton therapy technology is designed for targeted cancer treatment with significantly reduced treatment-related side effects. P-Cure's innovative upright solution, the world's first FDA-approved methodology for patient positioning, enables seated treatment, enhancing both patient comfort and clinical outcomes.

In February 2025, Ion Beam Applications S.A. (IBA), a Belgium-based provider of particle accelerator technology and proton therapy solutions, partnered with the Asian Institute of Gastroenterology (AIG) to enhance cancer care in South Asia through advanced proton therapy. Under the partnership, IBA will supply its ProteusONE compact proton therapy system to the new Oncology Centre at AIG Hospitals' Gachibowli campus in Hyderabad, India, supporting the expansion of state-of-the-art proton therapy capabilities in the region. AIG Hospitals is an India-based healthcare institution specializing in gastroenterology and comprehensive cancer care services.

Major companies operating in the particle therapy market are Hitachi Ltd., Mitsubishi Electric Corporation, Sumitomo Heavy Industries Ltd., Varian Medical Systems Inc., IBA Worldwide, Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.

North America was the largest region in the particle therapy market in 2025. Asia-Pacific is expected to be the fastest-growing region in the particle therapy market report during the forecast period. The regions covered in the particle therapy market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the particle therapy market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The particle therapy market includes of revenues earned by entities by providing particle therapy services such as treatment planning, particle beam delivery, imaging and simulation, treatment sessions, patient monitoring, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Particle Therapy Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses particle therapy market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for particle therapy ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The particle therapy market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Proton Therapy; Heavy Ion Therapy
  • 2) By System: Single-Room Systems; Multi-Room Systems
  • 3) By Cancer Type: Pediatric Cancer; Prostate Cancer; Lung Cancer; Brain And Spinal Cord Cancer; Other Cancer Types
  • 4) By End-User: Hospital; Academic And Research Centers
  • Subsegments:
  • 1) By Proton Therapy: Pencil Beam Scanning Proton Therapy; Passive Scattering Proton Therapy; Intensity-Modulated Proton Therapy (IMPT)
  • 2) By Heavy Ion Therapy: Carbon Ion Therapy; Helium Ion Therapy
  • Companies Mentioned: Hitachi Ltd.; Mitsubishi Electric Corporation; Sumitomo Heavy Industries Ltd.; Varian Medical Systems Inc.; IBA Worldwide; Mevion Medical Systems Inc.; ProNova Solutions LLC; Advanced Oncotherapy plc; Shinva Medical Instrument Co. Ltd.; Optivus Proton Therapy Inc.; Protom International Inc.; Danfysik AS; Toshiba Energy Systems And Solutions Corporation; Canon Medical Systems Corporation; Siemens Healthineers AG; Koninklijke Philips N.V.; GE Healthcare; Elekta AB; Accuray Incorporated; Xstrahl Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Particle Therapy Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Particle Therapy Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Particle Therapy Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Particle Therapy Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Artificial Intelligence & Autonomous Intelligence
    • 4.1.3 Industry 4.0 & Intelligent Manufacturing
    • 4.1.4 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Increasing Adoption Of Pencil Beam Scanning Systems
    • 4.2.2 Rising Deployment Of Single-Room Particle Therapy Centers
    • 4.2.3 Growing Use Of Carbon Ion Therapy
    • 4.2.4 Expansion Of Precision Treatment Planning Capabilities
    • 4.2.5 Enhanced Focus On Pediatric Oncology Applications

5. Particle Therapy Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Cancer Treatment Centers
  • 5.3 Academic And Research Centers
  • 5.4 Specialty Oncology Clinics
  • 5.5 Government Healthcare Institutions

6. Particle Therapy Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Particle Therapy Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Particle Therapy PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Particle Therapy Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Particle Therapy Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Particle Therapy Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Particle Therapy Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Particle Therapy Market Segmentation

  • 9.1. Global Particle Therapy Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Proton Therapy, Heavy Ion Therapy
  • 9.2. Global Particle Therapy Market, Segmentation By System, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single-Room Systems, Multi-Room Systems
  • 9.3. Global Particle Therapy Market, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pediatric Cancer, Prostate Cancer, Lung Cancer, Brain And Spinal Cord Cancer, Other Cancer Types
  • 9.4. Global Particle Therapy Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospital, Academic And Research Centers
  • 9.5. Global Particle Therapy Market, Sub-Segmentation Of Proton Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pencil Beam Scanning Proton Therapy, Passive Scattering Proton Therapy, Intensity-Modulated Proton Therapy (IMPT)
  • 9.6. Global Particle Therapy Market, Sub-Segmentation Of Heavy Ion Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Carbon Ion Therapy, Helium Ion Therapy

10. Particle Therapy Market Regional And Country Analysis

  • 10.1. Global Particle Therapy Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Particle Therapy Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Particle Therapy Market

  • 11.1. Asia-Pacific Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Particle Therapy Market

  • 12.1. China Particle Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Particle Therapy Market

  • 13.1. India Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Particle Therapy Market

  • 14.1. Japan Particle Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Particle Therapy Market

  • 15.1. Australia Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Particle Therapy Market

  • 16.1. Indonesia Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Particle Therapy Market

  • 17.1. South Korea Particle Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Particle Therapy Market

  • 18.1. Taiwan Particle Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Particle Therapy Market

  • 19.1. South East Asia Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Particle Therapy Market

  • 20.1. Western Europe Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Particle Therapy Market

  • 21.1. UK Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Particle Therapy Market

  • 22.1. Germany Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Particle Therapy Market

  • 23.1. France Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Particle Therapy Market

  • 24.1. Italy Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Particle Therapy Market

  • 25.1. Spain Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Particle Therapy Market

  • 26.1. Eastern Europe Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Particle Therapy Market

  • 27.1. Russia Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Particle Therapy Market

  • 28.1. North America Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Particle Therapy Market

  • 29.1. USA Particle Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Particle Therapy Market

  • 30.1. Canada Particle Therapy Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Particle Therapy Market

  • 31.1. South America Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Particle Therapy Market

  • 32.1. Brazil Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Particle Therapy Market

  • 33.1. Middle East Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Particle Therapy Market

  • 34.1. Africa Particle Therapy Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Particle Therapy Market, Segmentation By Type, Segmentation By System, Segmentation By Cancer Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Particle Therapy Market Regulatory and Investment Landscape

36. Particle Therapy Market Competitive Landscape And Company Profiles

  • 36.1. Particle Therapy Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Particle Therapy Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Particle Therapy Market Company Profiles
    • 36.3.1. Hitachi Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Mitsubishi Electric Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Sumitomo Heavy Industries Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Varian Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. IBA Worldwide Overview, Products and Services, Strategy and Financial Analysis

37. Particle Therapy Market Other Major And Innovative Companies

  • Mevion Medical Systems Inc., ProNova Solutions LLC, Advanced Oncotherapy plc, Shinva Medical Instrument Co. Ltd., Optivus Proton Therapy Inc., Protom International Inc., Danfysik AS, Toshiba Energy Systems And Solutions Corporation, Canon Medical Systems Corporation, Siemens Healthineers AG, Koninklijke Philips N.V., GE Healthcare, Elekta AB, Accuray Incorporated, Xstrahl Inc.

38. Global Particle Therapy Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Particle Therapy Market

40. Particle Therapy Market High Potential Countries, Segments and Strategies

  • 40.1 Particle Therapy Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Particle Therapy Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Particle Therapy Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer